Viewing StudyNCT00480584



Ignite Creation Date: 2024-05-05 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00480584
Status: COMPLETED
Last Update Posted: 2012-11-08
First Post: 2007-05-29

Brief Title: A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: H Lee Moffitt Cancer Center and Research Institute

Conditions & Keywords Data

Conditions:
Name
Metastatic Pancreatic Carcinoma
Keywords:
Name View
capecitabine View
pancreatic View
gemcitabine View
erlotinib HER1epidermal growth factor receptor EGFR tyrosine kinase inhibitor View